Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

CSL Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

30 Apr 2016 Reuters Investment Profile 12 $20.00

Wright Investors Service Comprehensive Report for CSL Limited

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

03 May 2016 Wright Reports 55 $75.00

Thomson Reuters Stock Report - CSL Ltd (CSL-AU)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

01 May 2016 Thomson Reuters Stock Report 11 $25.00

Wright Industry Averages: Pharmaceuticals & Biotechnology (Australasia)

Wright Investors' Service Industry Averages - Pharmaceuticals & Biotechnology (Australasia). Wright Industry Averages provide...

26 Apr 2016 Wright Reports 56 $169.00

Wright Industry Averages: Pharmaceuticals & Biotechnology (Australia)

Wright Investors' Service Industry Averages - Pharmaceuticals & Biotechnology (Australia). Wright Industry Averages provide c...

26 Apr 2016 Wright Reports 56 $169.00

CSL Limited

CSL Limited - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the com...

25 Apr 2016 MarketLine 47 $50.00

CSL Limited (CSL) - Financial and Strategic SWOT Analysis Review

CSL Limited (CSL) - Financial and Strategic SWOT Analysis Review Summary CSL Limited (CSL) is a specialty biotherapeutics com...

04 Apr 2016 GlobalData 90 $300.00

CSL Limited: Downgraded to Average

09 Mar 2016 Sadif Analytics Prime 3 $10.00

CSL Limited (CSL) - Financial and Strategic SWOT Analysis Review

CSL Limited (CSL) - Financial and Strategic SWOT Analysis Review Summary CSL Limited (CSL) is a specialty biotherapeutics com...

02 Mar 2016 GlobalData 89 $300.00

CSL Limited (ASX-CSL)

The CSL Group has more than 90 years’ experience in the development and manufacture of vaccines and plasma protein biotherap...

24 Feb 2016 Acquisdata 15 $15.00